<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASeries_C</id>
	<title>Definition:Series C - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASeries_C"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Series_C&amp;action=history"/>
	<updated>2026-05-02T22:17:17Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Series_C&amp;diff=19703&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Series_C&amp;diff=19703&amp;oldid=prev"/>
		<updated>2026-03-17T06:19:32Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🚀 &amp;#039;&amp;#039;&amp;#039;Series C&amp;#039;&amp;#039;&amp;#039; is an advanced venture capital financing round that, in the [[Definition:Insurtech | insurtech]] sector, signals a company has moved beyond product validation and initial scaling into a phase of aggressive growth, market consolidation, or preparation for a public listing or strategic exit. By the time an insurance technology company reaches Series C, it is typically generating meaningful [[Definition:Gross written premium (GWP) | gross written premium]] (if risk-bearing) or substantial recurring revenue (if operating as a technology vendor), and the round is designed to fund major geographic expansion, acquisitions, product line extensions, or the capital reserves needed to support rapid premium growth.&lt;br /&gt;
&lt;br /&gt;
⚙️ The investor profile at Series C shifts noticeably compared to earlier rounds. While [[Definition:Series A | Series A]] and [[Definition:Series B | Series B]] rounds are often led by venture capital specialists, Series C frequently attracts later-stage growth equity firms, [[Definition:Private equity | private equity]] investors, sovereign wealth funds, and large strategic players from within the insurance industry itself. For risk-bearing insurtechs — particularly those operating as [[Definition:Managing general agent (MGA) | MGAs]] or licensed [[Definition:Insurance carrier | carriers]] — the round may partly fund the [[Definition:Surplus | surplus]] or [[Definition:Regulatory capital | regulatory capital]] required to support an expanding book of business, a dynamic largely absent from typical technology fundraising. Valuation negotiations at this stage rely heavily on insurance-specific financial performance: investors scrutinize [[Definition:Loss ratio | loss ratio]] trends, [[Definition:Combined ratio | combined ratio]] trajectories, [[Definition:Retention rate | policy retention rates]], and the quality and durability of [[Definition:Capacity | capacity]] arrangements with reinsurers. The due diligence process also examines regulatory standing across multiple jurisdictions, since a company at this stage is likely operating — or planning to operate — in several markets with distinct [[Definition:Regulatory compliance | compliance]] requirements.&lt;br /&gt;
&lt;br /&gt;
🌐 Reaching Series C in insurance technology carries strategic weight beyond the capital itself. It signals to the broader market — [[Definition:Reinsurance | reinsurers]], [[Definition:Broker | brokers]], regulators, and potential enterprise customers — that sophisticated institutional investors have vetted the company&amp;#039;s model and believe it can sustain long-term growth in a notoriously complex industry. This credibility is particularly valuable in insurance, where counterparty trust and financial stability are prerequisites for meaningful [[Definition:Distribution | distribution]] partnerships. Historically, several high-profile insurtechs have used Series C rounds to pivot or refine their models — some moving from direct-to-consumer approaches toward B2B2C or wholesale strategies after learning the true cost of customer acquisition in personal lines. The round thus represents not just a capital infusion but often a strategic inflection point that defines the company&amp;#039;s identity for the next chapter of its development.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Series B]]&lt;br /&gt;
* [[Definition:Initial public offering (IPO)]]&lt;br /&gt;
* [[Definition:Insurtech]]&lt;br /&gt;
* [[Definition:Private equity]]&lt;br /&gt;
* [[Definition:Growth equity]]&lt;br /&gt;
* [[Definition:Venture capital]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>